drugset / Trial / NCT04726592

Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

NCT04726592

Phase 3 Terminated 323 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room

Timeline

Start
2021-07-08
Primary completion
2024-04-10
Completion
2024-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clorazepate Small molecule 20 mg Intravenous
Background Ketoprofen Small molecule 100 mg Intravenous
Background Metoclopramide Small molecule 10 mg Intravenous